Browsing by Author "carcereny, Enric"
Now showing items 1-5 of 5
-
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study
Ruano-Ravina, Alberto; Calvo de Juan, Virginia; Estival, Anna; Benítez, Gretel; Belver, Marta; Guirado Risueño, María; Guirao Rubio, Carlos Miguel; Blasco Cordellat, Ana; Ortega Granados, Ana Laura; Mosquera-Martínez, Joaquín; Aguado, Carlos; Bosch-Barrera, J; Sanchez Gastaldo, Amparo; del Barco Morillo, Edel; Juan, Óscar; Domine, Manuel; Trigo, José Manuel; Pereiro Corbacho. Diego; Oramas, Juana; Carcereny, Enric; Rodriguez-Abreu, Delvys; Provencio, Mariano; Lopez Castro, Rafael; Cobo, Manuel; Massuti, Bartomeu (AME Publishing, 2021-10) -
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study
Viñolas, N. Nuria; Garcia‑Campelo, Rosario; Majem Tarruella, Margarita; Isla, Dolores; Gonzalez‑Larriba, José Luis; Felip Font, Enriqueta; Carcereny, Enric (BMC, 2020-11-23) -
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
Herbst, Roy; Majem Tarruella, Margarita; Barlesi, Fabrice; Chu, Quincy; Monnet, Isabelle; Martínez Marti, Alexandre; Carcereny, Enric (American Society of Clinical Oncology, 2022-10-10) -
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
Provencio Pulla, Mariano; Rodriguez-Abreu, Delvys; Calvo, Virginia; carcereny, Enric; Cantero, Alexandra; Blanco, Remei; Cobo, Manuel (BMC, 2022-07-05) -
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
Gutiérrez, Lourdes; Royuela, Ana; Lopez Castro, Rafael; carcereny, Enric; Rodriguez-Abreu, Delvys; Blanco, Remei; Massuti, Bartomeu (BMC, 2021-08-31)